Therefore, EGF-dose-dependence of the pY1068/EGFR ratio measured using a 10-min stimulation of cells in vitro was employed as a linear standard to estimate ligand concentrations in vivo in tumor xenografts. The gene discussed is EGF; the disease is neoplasm.